Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease [NA]
A recruiting study evaluating sleep impairment in individuals at risk of developing Alzheimer's disease.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Lifestyle for the BRAin Health - Time Restricted Eating and Mindfulness [NA]
A recruiting clinical trial evaluating lifestyle interventions—time-restricted eating, mindfulness, and yoga—for brain health in adults with…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Old School Hip Hop: Parent Follow-Up & Spanish Speakers Inclusion [NA]
A clinical trial update indicates the study has completed and highlights follow-up activities with parents and inclusion of Spanish-speaking…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Study of Caregiver Connections Via Technology in Dementia [NA]
A Mayo Clinic study evaluates technology-assisted caregiver connections for people with dementia and related conditions. The study covers Al…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE) [NA]
A completed clinical trial (COPE in PACE) evaluating care for persons with dementia; results have been posted on 2025-06-26.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease [NA]
A clinical trial is investigating whether transcranial magnetic stimulation can slow cognitive decline in Alzheimer disease and is currently…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Financial Incentives and Recruitment to the APT Webstudy [NA]
This entry reports a USC-sponsored clinical trial update on using financial incentives to recruit participants to the APT Webstudy for Alzhe…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Validation of a Remediation Method for Memory Disorders Using Motor and Emotional Encoding in Patients With Alzheimer's Disease [NA]
A completed clinical trial validating a remediation method using motor and emotional encoding to address memory disorders in Alzheimer's dis…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: 12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease [Phase 4]
This Phase 4 trial update reports 12-month real-world safety and efficacy data for lecanemab in early Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment [NA]
A completed clinical trial (NCT05411822) evaluating circadian responses to light in people with mild cognitive impairment and Alzheimer dise…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Olfactory Biopsies [NA]
Clinical trial update indicating recruiting status for a study on olfactory biopsies in Alzheimer's disease and smell disorders.
-
FDA approval · 2025-06-23FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for AMYVID (florbetapir F-18) submitted by Eli Lilly and Company. The action relates to the imag…
-
FDA approval · 2025-06-23FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for VIZAMYL (flutemetamol F-18) from GE Healthcare.
-
FDA approval · 2025-06-23FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (Florbetaben F 18) submitted by Lantheus Biosciences Ltd.
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes [NA]
An ongoing Indiana University clinical trial aims to enhance shared decision-making to guide care for people with diabetes and dementia/Alzh…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: The COMFORTage Project at Ace Alzheimer Center Barcelona [NA]
This is a clinical trial update for the COMFORTage project at Ace Alzheimer Center Barcelona, studying Alzheimer’s disease and mild cognitiv…
-
EMA approval · 2025-06-20EMA Authorised: Memantine Merz (memantine hydrochloride) — Merz Pharmaceuticals GmbH
EMA authorised Memantine Merz (memantine hydrochloride) for Alzheimer’s disease.
-
EMA approval · 2025-06-20EMA Authorised: Axura (memantine hydrochloride) — Merz Pharmaceuticals GmbH
EMA authorised Axura (memantine hydrochloride) by Merz Pharmaceuticals GmbH for the treatment of Alzheimer disease. This marks EU marketing …
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: The BRAIN App (Phase 2 SBIR) [NA]
A Phase 2 SBIR trial evaluating The BRAIN App for dementia, including Alzheimer's disease and vascular dementia, is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Swallowing Impairments in Adults With and Without Alzheimer's Disease
A Vanderbilt University Medical Center-led clinical study is investigating swallowing impairments (dysphagia) in adults with and without Alz…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) [Phase 2]
A Phase 2 study evaluating SAGE-718 in individuals with mild cognitive impairment or mild dementia due to Alzheimer's disease has completed,…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: The Link Between Physical Activity and Brain Health in Healthy Adults
A clinical trial update describes a study in healthy adults examining the link between physical activity and brain health, with Alzheimer's …
-
FDA approval · 2025-06-16FDA Approved: RIVASTIGMINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA has approved a supplemental application for rivastigmine from Zydus Pharmaceuticals USA Inc., indicating an approved change to the gener…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Effects of a Cognitive-Engaging Strength Training Program on Health, Physical Condition, and Quality of Life in People With Alzheimer's Disease [NA]
This clinical trial update describes a study evaluating a cognitive-engaging strength training program for people with Alzheimer disease; th…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia [NA]
A Northwestern University–led clinical trial is recruiting to characterize variability in hearing aid outcomes among older adults with Alzhe…